Home › Asset managers › Compare 2024-2025 › Brighthouse vs AIG/SunAmerica
Note on Brighthouse: its funds did not all vote the same way on 14.7% of the 97,681 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
Brighthouse 2024-2025 · AIG/SunAmerica 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 44,314 | 31,634 | 370 | 12,310 | 98.8% | 90.6% |
| Board proposals | 37,908 | 26,262 | 285 | 11,361 | 98.9% | 90.3% |
| E&S shareholder proposals | 257 | 2 | 2 | 253 | 50.0% | 49.5% |
| Other items | 6,149 | 5,370 | 83 | 696 | 98.5% | 94.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
11,361 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Brighthouse | AIG/SunAmerica |
|---|---|---|---|---|---|---|
| ARCOSA INC. | May 14, 2025 | Ratification of Ernst & Young LLP as Arcosa's independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | Split 8 FOR, 1 ABSTAIN |
FOR 5 funds |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | Election of Directors: Andrew Perlman, M.D., Ph.D. Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | Election of Directors: Yasunori Kaneko, M.D. Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 2 FOR, 2 ABSTAIN |
FOR 2 funds |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 2 FOR, 2 ABSTAIN |
FOR 2 funds |
| ARCUTIS BIOTHERAPEUTICS INC. | June 12, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 4 AGAINST, 1 ABSTAIN |
AGAINST 3 funds |
| ARCUTIS BIOTHERAPEUTICS INC. | June 12, 2025 | To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARDELYX INC. | June 18, 2025 | To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | Split 1 AGAINST, 1 ABSTAIN |
AGAINST 3 funds |
| ARDELYX INC. | June 18, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). Say-on-Pay |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARDELYX INC. | June 18, 2025 | To ratify the selection, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARDENT HEA | May 21, 2025 | Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. Say-on-Pay |
Board | Not determined | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARDENT HEA | May 21, 2025 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | Not determined | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Approval, on a non-binding, advisory basis, of the compensation paid to our named executive officers for our 2024 fiscal year. Say-on-Pay |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Antoinette Bush Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Antony P. Ressler Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Ashish Bhutani Director Elections |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Bennett Rosenthal Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: David B. Kaplan Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Dr. Judy D. Olian Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Eileen Naughton Director Elections |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Michael J Arougheti Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Michael Lynton Director Elections |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: Paul G. Joubert Director Elections |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | Election of Directors: R. Kipp deVeer Director Elections |
Board | For | Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
AGAINST 6 funds |
| ARES MANAGEMENT CORP. | June 6, 2025 | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our 2025 fiscal year. Audit-related |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 6 funds |
| ARGENX SE | May 27, 2025 | Approve Remuneration Policy Compensation |
Board | For | Split 4 FOR, 2 AGAINST |
AGAINST 6 funds |
| ARGENX SE | May 27, 2025 | Approve Remuneration Report Compensation |
Board | For | Split 3 FOR, 3 AGAINST |
AGAINST 6 funds |
| ARISTA NETWORKS INC. | May 30, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 2 FOR, 6 AGAINST, 2 ABSTAIN |
AGAINST 20 funds |
| ARISTA NETWORKS INC. | May 30, 2025 | Election of Directors: Charles Giancarlo Director Elections |
Board | For | Split 5 FOR, 1 WITHHOLD |
FOR 20 funds |
| ARISTA NETWORKS INC. | May 30, 2025 | Election of Directors: Daniel Scheinman Director Elections |
Board | For | Split 2 FOR, 4 WITHHOLD |
WITHHOLD 20 funds |
| ARISTA NETWORKS INC. | May 30, 2025 | Election of Directors: Yvonne Wassenaar Director Elections |
Board | For | Split 1 FOR, 5 WITHHOLD |
WITHHOLD 20 funds |
| ARISTA NETWORKS INC. | May 30, 2025 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 8 FOR, 2 ABSTAIN |
FOR 20 funds |
| ARISTOCRAT LEISURE LTD. | February 20, 2025 | Approve Grant of Performance Share Rights to Trevor Croker Under the Long-Term Incentive Plan Compensation |
Board | For | Split 1 FOR, 5 AGAINST |
AGAINST 8 funds |
| ARKEMA SA | May 22, 2025 | Reelect Bpifrance Investissement as Director Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 2 funds |
| ARKEMA SA | May 22, 2025 | Reelect Ilse Henne as Director Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 2 funds |
| ARKEMA SA | May 22, 2025 | Reelect Thierry Pilenko as Director Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 2 funds |
| ARLO TECHNOLOGIES INC. | June 20, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 3 AGAINST, 1 ABSTAIN |
AGAINST 2 funds |
| ARLO TECHNOLOGIES INC. | June 20, 2025 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 2 funds |
| ARMADA HOFFLER PROPERTIES INC. | June 18, 2025 | Election of Directors: F. Blair Wimbush Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 3 funds |
| ARMADA HOFFLER PROPERTIES INC. | June 18, 2025 | Election of Directors: George F. Allen Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 3 funds |
| ARMADA HOFFLER PROPERTIES INC. | June 18, 2025 | Election of Directors: James C. Cherry Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 3 funds |
| ARMSTRONG WORLD INDUSTRIES INC. | June 12, 2025 | To approve, on an advisory basis, our executive compensation program. Say-on-Pay |
Board | For | Split 4 FOR, 1 AGAINST, 3 ABSTAIN |
FOR 5 funds |
| ARMSTRONG WORLD INDUSTRIES INC. | June 12, 2025 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2025. Audit-related |
Board | For | Split 4 FOR, 1 AGAINST, 3 ABSTAIN |
FOR 5 funds |
| ARROW ELECTRONICS INC. | May 6, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | Split 2 FOR, 2 ABSTAIN |
FOR 6 funds |
| ARROW ELECTRONICS INC. | May 6, 2025 | To ratify the appointment of Ernst & Young LLP as Arrow's independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 2 FOR, 2 ABSTAIN |
FOR 6 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Adeoye Olukotun Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Christopher Anzalone Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Hongbo Lu Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Mauro Ferrari Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Michael S. Perry Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Victoria Vakiener Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: William Waddill Director Elections |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | To ratify the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2025. Audit-related |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 4 funds |
| ARS PHARMACEUTICALS INC. | June 25, 2025 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 1 FOR, 2 ABSTAIN |
FOR 2 funds |
| ARTERIS INC. | June 3, 2025 | To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Deloitte & Touche LLP, as the independent registered public accounting firm and independent auditor of the Company for its year ending December 31, 2025. Audit-related |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 2 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Chris Miskel Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: David Johnson Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Deborah Caplan Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: John Coldman Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Norman Rosenthal Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Pat Gallagher Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Ralph Nicoletti Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Richard Harries Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Sherry Barrat Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTHUR J. GALLAGHER & CO. | May 13, 2025 | Election of Directors: Teresa Clarke Director Elections |
Board | For | Split 6 FOR, 4 ABSTAIN |
FOR 17 funds |
| ARTISAN PARTNERS ASSET MANAGEMENT INC | June 4, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARTISAN PARTNERS ASSET MANAGEMENT INC | June 4, 2025 | Ratification of the Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025. Audit-related |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARVINAS INC. | June 25, 2025 | Election of three Class I directors: John Houston, Ph.D. Director Elections |
Board | For | Split 1 FOR, 3 WITHHOLD |
WITHHOLD 3 funds |
| ARVINAS INC. | June 25, 2025 | Election of three Class I directors: Laurie Smaldone Alsup, M.D. Director Elections |
Board | For | Split 1 FOR, 3 WITHHOLD |
WITHHOLD 3 funds |
| ARVINAS INC. | June 25, 2025 | Election of three Class I directors: Linda Bain Director Elections |
Board | For | Split 1 FOR, 3 WITHHOLD |
WITHHOLD 3 funds |
| ARVINAS INC. | June 25, 2025 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ARVINAS INC. | June 25, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASAHI KASEI CORP. | June 25, 2025 | Elect Director Kudo, Koshiro Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 7 funds |
| ASANA INC. | June 16, 2025 | Approval, on an advisory basis, of the compensation of the Company's named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 4 funds |
| ASANA INC. | June 16, 2025 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2026. Audit-related |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 4 funds |
| ASBURY AUTOMOTIVE GROUP INC. | May 13, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 8 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASBURY AUTOMOTIVE GROUP INC. | May 13, 2025 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | Split 8 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASCENDIS PHARMA A/S | May 27, 2025 | Approve Issuance of Warrants to Board Members Compensation |
Board | For | Split 2 FOR, 2 AGAINST |
AGAINST 3 funds |
| ASGN INC. | June 12, 2025 | Advisory vote to approve named executive officer compensation for the year ended December 31, 2024. Say-on-Pay |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 5 funds |
| ASGN INC. | June 12, 2025 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 5 funds |
| ASHLAND IN | January 21, 2025 | Approval of the non-binding advisory resolution approving the compensation paid to Ashland's named executive officers. Say-on-Pay |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Ashish K. Kulkarni Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Guillermo Novo Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Jerome A. Peribere Director Elections |
Board | Not determined | Split 3 FOR, 1 AGAINST, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Sanat Chattopadhyay Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Scott A. Tozier Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Sergio Pedreiro Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Steven D. Bishop Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Susan L. Main Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Election of Directors: Suzan F. Harrison Director Elections |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHLAND IN | January 21, 2025 | Ratification of the appointment of Ernst & Young LLP as Ashland's independent registered public accounting firm for the fiscal year 2025. Audit-related |
Board | Not determined | Split 4 FOR, 1 ABSTAIN |
FOR 3 funds |
| ASHTEAD GROUP PLC | September 4, 2024 | Amend Long-Term Incentive Plan Compensation |
Board | For | Split 1 FOR, 4 AGAINST |
AGAINST 11 funds |
| ASHTEAD GROUP PLC | September 4, 2024 | Approve Remuneration Policy Compensation |
Board | For | Split 1 FOR, 4 AGAINST |
AGAINST 11 funds |
| ASPEN TECHNOLOGY INC. | December 17, 2024 | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2025. Audit-related |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 2 funds |
| ASSA ABLOY AB | April 23, 2025 | Approve Performance Share Matching Plan LTI 2025 for Senior Executives and Key Employees Compensation |
Board | For | Split 1 FOR, 4 AGAINST |
AGAINST 5 funds |
| ASSOCIATED | April 29, 2025 | Advisory approval of Associated Banc-Corp's named executive officer compensation. Say-on-Pay |
Board | Not determined | Split 8 FOR, 1 ABSTAIN |
FOR 7 funds |
| ASSURANT INC. | May 21, 2025 | Advisory approval of the 2024 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 6 FOR, 1 AGAINST, 1 ABSTAIN |
FOR 7 funds |
| ASSURANT INC. | May 21, 2025 | Election of Directors: Debra J. Perry Director Elections |
Board | For | Split 7 FOR, 1 ABSTAIN |
FOR 7 funds |
| ASSURANT INC. | May 21, 2025 | Election of Directors: Elaine D. Rosen Director Elections |
Board | For | Split 7 FOR, 1 ABSTAIN |
FOR 7 funds |
← Previous Page 10 of 114 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.